Stockreport

Atai Life Sciences (ATAI): How NIDA's $11.4M Grant Shapes the Valuation Outlook [Yahoo! Finance]

Atai Beckley N.V - Common Shares  (ATAI) 
US:NASDAQ Investor Relations: ir.atai.net.cn
PDF National Institute on Drug Abuse to fund the early development of its novel, non-hallucinogenic 5-HT2A/2C receptor agonists for opioid use disorder. For investors, this [Read more]